BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26208847)

  • 21. Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors.
    Galván JA; Astudillo A; Vallina A; Crespo G; Folgueras MV; González MV
    BMC Cancer; 2014 Nov; 14():855. PubMed ID: 25413006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
    Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
    J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma.
    Yantiss RK; Goodarzi M; Zhou XK; Rennert H; Pirog EC; Banner BF; Chen YT
    Am J Surg Pathol; 2009 Apr; 33(4):572-82. PubMed ID: 19047896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
    Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
    Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
    Gao ZH; Lu C; Wang ZN; Song YX; Zhu JL; Gao P; Sun JX; Chen XW; Wang MX; Dong YL; Xu HM
    Histopathology; 2014 Oct; 65(4):527-38. PubMed ID: 24738665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach.
    Flucke U; Flucke MT; Hoy L; Breuer E; Goebbels R; Rhiem K; Schmutzler R; Winzenried H; Braun M; Steiner S; Buettner R; Gevensleben H
    Histopathology; 2010 Jun; 56(7):852-9. PubMed ID: 20636789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
    Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of leucine zipper putative tumor suppressor 1 is associated with poor prognosis, increased cell motility and invasion, and epithelial-to-mesenchymal transition characteristics in human breast carcinoma.
    Wang XX; Zhu Z; Su D; Lei T; Wu X; Fan Y; Li X; Zhao J; Fu L; Dong JT; Fu L
    Hum Pathol; 2011 Oct; 42(10):1410-9. PubMed ID: 21419475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy.
    Sakamoto K; Imanishi Y; Tomita T; Shimoda M; Kameyama K; Shibata K; Sakai N; Ozawa H; Shigetomi S; Fujii R; Fujii M; Ogawa K
    Ann Surg Oncol; 2012 Feb; 19(2):612-9. PubMed ID: 21913013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
    Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
    Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive KL-6 mucin expression combined with decreased membranous beta-catenin expression indicates worse prognosis in colorectal carcinoma.
    Zhang W; Tang W; Inagaki Y; Qiu M; Xu HL; Li X; Sugawara Y; Nagawa H; Nakata M; Kokudo N
    Oncol Rep; 2008 Nov; 20(5):1013-9. PubMed ID: 18949395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosing colorectal medullary carcinoma: interobserver variability and clinicopathological implications.
    Lee LH; Yantiss RK; Sadot E; Ren B; Calvacanti MS; Hechtman JF; Ivelja S; Huynh B; Xue Y; Shitilbans T; Guend H; Stadler ZK; Weiser MR; Vakiani E; Gönen M; Klimstra DS; Shia J
    Hum Pathol; 2017 Apr; 62():74-82. PubMed ID: 28034727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Lauren classification highlights the role of epithelial-to-mesenchymal transition in gastric carcinogenesis: an immunohistochemistry study of the STAT3 and adhesion molecules expression.
    Susman S; Barnoud R; Bibeau F; Borrini F; Pocard M; Tomuleasa C; Sabourin JC
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):77-83. PubMed ID: 25822437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between β-catenin expression and prognostic parameters of colorectal carcinomas.
    Peker K; Başoğlu M; Gürsan N
    Turk Patoloji Derg; 2013; 29(2):87-93. PubMed ID: 23661344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and beta-catenin, in prostate cancer.
    Contreras HR; Ledezma RA; Vergara J; Cifuentes F; Barra C; Cabello P; Gallegos I; Morales B; Huidobro C; Castellón EA
    Urol Oncol; 2010; 28(5):534-40. PubMed ID: 19450993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced expression of hepatocyte growth factor activator inhibitor type 2-related small peptide at the invasive front of colon cancers.
    Uchiyama S; Itoh H; Naganuma S; Nagaike K; Fukushima T; Tanaka H; Hamasuna R; Chijiiwa K; Kataoka H
    Gut; 2007 Feb; 56(2):215-26. PubMed ID: 16809422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poorly differentiated clusters (PDC) in colorectal cancer: Does their localization in tumor matter?
    Bertoni L; Barresi V; Bonetti LR; Caramaschi S; Mangogna A; Lionti S; Azzoni P; Carnevale G; Pisciotta A; Salviato T
    Ann Diagn Pathol; 2019 Aug; 41():106-111. PubMed ID: 31233902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
    Harada K; Miyake H; Kusuda Y; Fujisawa M
    BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma.
    Fujioka T; Takebayashi Y; Kihana T; Kusanagi Y; Hamada K; Ochi H; Uchida T; Fukumoto M; Ito M
    Oncol Rep; 2001; 8(2):249-55. PubMed ID: 11182035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.